[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274) | Capital Allocators – Inside the Institutional Investment Industry

This podcast episode delves into the fascinating world of biotech investing, exploring the latest advancements in disease treatment, gene therapy, and the challenges faced by healthcare companies. Andy Acker, a seasoned portfolio manager in the healthcare space, shares his insights and investment strategies, highlighting the importance of conviction, risk management, and spotting undervalued companies with promising products, even amidst bear markets.

Outlines

Sign in to continue reading, translating and more.

Continue

[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Capital Allocators – Inside the Institutional Investment Industry

Andy Acker's Journey to Becoming a Healthcare Investor

The Advancements in Biotech and Their Impact on Investing

Unlocking the Power of Biotechnology: Innovations in Disease Treatment

Uncovering the Challenges and Opportunities in Pharmaceutical Development and Commercialization

Navigating the Biotech Sector: Understanding the Three P's and Identifying Opportunities

Navigating the Biotech Bear Market: Identifying Opportunities Amidst Market Volatility

Evaluating Companies for Investment: Focusing on Unmet Medical Needs and Efficient Healthcare

The Importance of Management Teams in the Pharmaceutical Industry

Investment Strategies and Portfolio Construction in Healthcare

Navigating Healthcare Investments: Balancing Risk and Reward

Gene Therapy: A Revolutionary Approach to Treating Genetic Diseases

Innovative Therapies for Unmet Medical Needs: Addressing Drug Pricing Concerns

Navigating the Biotech Bear Market: Green Shoots and Challenges

Navigating the Challenges of Biotech Investing: Insights from Andy Adams

[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)

Capital Allocators – Inside the Institutional Investment Industry

00:05Andy Acker's Journey to Becoming a Healthcare Investor

Andy Acker's Journey to Becoming a Healthcare Investor

03:42The Advancements in Biotech and Their Impact on Investing

The Advancements in Biotech and Their Impact on Investing

06:38Unlocking the Power of Biotechnology: Innovations in Disease Treatment

Unlocking the Power of Biotechnology: Innovations in Disease Treatment

12:08Uncovering the Challenges and Opportunities in Pharmaceutical Development and Commercialization

Uncovering the Challenges and Opportunities in Pharmaceutical Development and Commercialization

16:07Navigating the Biotech Sector: Understanding the Three P's and Identifying Opportunities

Navigating the Biotech Sector: Understanding the Three P's and Identifying Opportunities

20:19Navigating the Biotech Bear Market: Identifying Opportunities Amidst Market Volatility

Navigating the Biotech Bear Market: Identifying Opportunities Amidst Market Volatility

25:20Evaluating Companies for Investment: Focusing on Unmet Medical Needs and Efficient Healthcare

Evaluating Companies for Investment: Focusing on Unmet Medical Needs and Efficient Healthcare

28:15The Importance of Management Teams in the Pharmaceutical Industry

The Importance of Management Teams in the Pharmaceutical Industry

32:43Investment Strategies and Portfolio Construction in Healthcare

Investment Strategies and Portfolio Construction in Healthcare

35:31Navigating Healthcare Investments: Balancing Risk and Reward

Navigating Healthcare Investments: Balancing Risk and Reward

38:47Gene Therapy: A Revolutionary Approach to Treating Genetic Diseases

Gene Therapy: A Revolutionary Approach to Treating Genetic Diseases

41:34Innovative Therapies for Unmet Medical Needs: Addressing Drug Pricing Concerns

Innovative Therapies for Unmet Medical Needs: Addressing Drug Pricing Concerns

45:17Navigating the Biotech Bear Market: Green Shoots and Challenges

Navigating the Biotech Bear Market: Green Shoots and Challenges

48:17Navigating the Challenges of Biotech Investing: Insights from Andy Adams

Navigating the Challenges of Biotech Investing: Insights from Andy Adams